Literature DB >> 30742063

Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy.

Yevgen Chornenkyy1, David W Fardo2,3, Peter T Nelson4,5.   

Abstract

We review the literature on Tau and TDP-43 proteinopathies in aged human brains and the relevant underlying pathogenetic cascades. Complex interacting pathways are implicated in Alzheimer's disease and related dementias (ADRD), wherein multiple proteins tend to misfold in a manner that is "reactive," but, subsequently, each proteinopathy may contribute strongly to the clinical symptoms. Tau proteinopathy exists in brains of individuals across a broad spectrum of primary underlying conditions-e.g., developmental, traumatic, and inflammatory/infectious diseases. TDP-43 proteinopathy is also expressed in a wide range of clinical disorders.  Although TDP-43 proteinopathy was first described in the central nervous system of patients with amyotrophic lateral sclerosis (ALS) and in subtypes of frontotemporal dementia (FTD/FTLD), TDP-43 proteinopathy is also present in chronic traumatic encephalopathy, cognitively impaired persons in advanced age with hippocampal sclerosis, Huntington's disease, and other diseases. We list known Tau and TDP-43 proteinopathies.  There is also evidence of cellular co-localization between Tau and TDP-43 misfolded proteins, suggesting common pathways or protein interactions facilitating misfolding in one protein by the other. Multiple pleiotropic gene variants can alter risk for Tau or TDP-43 pathologies, and certain gene variants (e.g., APOE ε4, Huntingtin triplet repeats) are associated with increases of both Tau and TDP-43 proteinopathies. Studies of genetic risk factors have provided insights into multiple nodes of the pathologic cascades involved in Tau and TDP-43 proteinopathies. Variants from a specific gene can be either a low-penetrant risk factor for a group of diseases, or alternatively, a different variant of the same gene may be a disease-driving allele that is associated with a relatively aggressive and early-onset version of a clinically and pathologically specific disease type. Overall, a complex but enlightening paradigm has emerged, wherein both Tau and TDP-43 proteinopathies are linked to numerous overlapping upstream influences, and both are associated with multiple downstream pathologically- and clinically-defined deleterious effects.

Entities:  

Mesh:

Year:  2019        PMID: 30742063      PMCID: PMC6609463          DOI: 10.1038/s41374-019-0196-y

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  27 in total

1.  TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.

Authors:  Mauro Montalbano; Salome McAllen; Filippa Lo Cascio; Urmi Sengupta; Stephanie Garcia; Nemil Bhatt; Anna Ellsworth; Eric A Heidelman; Omar D Johnson; Samantha Doskocil; Rakez Kayed
Journal:  Neurobiol Dis       Date:  2020-10-14       Impact factor: 5.996

2.  Novel monoclonal antibodies targeting the RRM2 domain of human TDP-43 protein.

Authors:  Jorge A Trejo-Lopez; Zachary A Sorrentino; Cara J Riffe; Grace M Lloyd; Sydney A Labuzan; Dennis W Dickson; Anthony T Yachnis; Stefan Prokop; Benoit I Giasson
Journal:  Neurosci Lett       Date:  2020-09-06       Impact factor: 3.046

Review 3.  Poly(ADP-Ribosylation) in Age-Related Neurological Disease.

Authors:  Leeanne McGurk; Olivia M Rifai; Nancy M Bonini
Journal:  Trends Genet       Date:  2019-06-07       Impact factor: 11.639

4.  Granulins modulate liquid-liquid phase separation and aggregation of the prion-like C-terminal domain of the neurodegeneration-associated protein TDP-43.

Authors:  Anukool A Bhopatkar; Vladimir N Uversky; Vijayaraghavan Rangachari
Journal:  J Biol Chem       Date:  2020-01-06       Impact factor: 5.157

5.  Differences in Symptomatic Presentation and Cognitive Performance Among Participants With LATE-NC Compared to FTLD-TDP.

Authors:  Merilee A Teylan; Charles Mock; Kathryn Gauthreaux; Jessica E Culhane; Gregory Jicha; Yen-Chi Chen; Kwun C G Chan; Walter A Kukull; Peter T Nelson; Yuriko Katsumata
Journal:  J Neuropathol Exp Neurol       Date:  2021-10-01       Impact factor: 3.685

6.  Locus Coeruleus Degeneration Differs Between Frontotemporal Lobar Degeneration Subtypes.

Authors:  Nathalie Matti; Keivan Javanshiri; Mattias Haglund; Xavier Saenz-Sardá; Elisabet Englund
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

7.  Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts.

Authors:  Peter T Nelson; Carol Brayne; Margaret E Flanagan; Erin L Abner; Sonal Agrawal; Johannes Attems; Rudolph J Castellani; Maria M Corrada; Matthew D Cykowski; Jing Di; Dennis W Dickson; Brittany N Dugger; John F Ervin; Jane Fleming; Jonathan Graff-Radford; Lea T Grinberg; Suvi R K Hokkanen; Sally Hunter; Alifiya Kapasi; Claudia H Kawas; Hannah A D Keage; C Dirk Keene; Mia Kero; David S Knopman; Naomi Kouri; Gabor G Kovacs; Sydney A Labuzan; Eric B Larson; Caitlin S Latimer; Renata E P Leite; Billie J Matchett; Fiona E Matthews; Richard Merrick; Thomas J Montine; Melissa E Murray; Liisa Myllykangas; Sukriti Nag; Ruth S Nelson; Janna H Neltner; Aivi T Nguyen; Ronald C Petersen; Tuomo Polvikoski; R Ross Reichard; Roberta D Rodriguez; Claudia K Suemoto; Shih-Hsiu J Wang; Stephen B Wharton; Lon White; Julie A Schneider
Journal:  Acta Neuropathol       Date:  2022-06-13       Impact factor: 15.887

8.  Limbic-Predominant Age-Related TDP-43 Encephalopathy: Medical and Pathologic Factors Associated With Comorbid Hippocampal Sclerosis.

Authors:  Kathryn M Gauthreaux; Merilee A Teylan; Yuriko Katsumata; Charles Mock; Jessica E Culhane; Yen-Chi Chen; Kwun C G Chan; David W Fardo; Adam J Dugan; Matthew D Cykowski; Gregory A Jicha; Walter A Kukull; Peter T Nelson
Journal:  Neurology       Date:  2022-02-04       Impact factor: 11.800

9.  Reply: Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer's disease with and without associated TDP-43 proteinopathy.

Authors:  Peter T Nelson
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

10.  Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration.

Authors:  John L Robinson; Sílvia Porta; Filip G Garrett; Panpan Zhang; Sharon X Xie; EunRan Suh; Vivianna M Van Deerlin; Erin L Abner; Gregory A Jicha; Justin M Barber; Virginia M-Y Lee; Edward B Lee; John Q Trojanowski; Peter T Nelson
Journal:  Brain       Date:  2020-09-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.